Kuros Biosciences AG

CSBTF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$17,460$14,208$24,065$28,623
Short-Term Investments$0$0$0$0
Receivables$14,932$6,411$3,347$1,876
Inventory$9,443$4,856$3,170$1,757
Other Curr. Assets$2,919$1,719$811$636
Total Curr. Assets$44,754$27,194$31,393$32,892
Property Plant & Equip (Net)$3,024$2,642$2,323$2,447
Goodwill$19,433$24,469$29,314$33,390
Intangibles$14,991$16,508$19,412$22,607
Long-Term Investments$0$16,508$51,049$53,464
Tax Assets$2,336$0$504$4,980
Other NC Assets$0-$15,857-$51,049-$58,444
Total NC Assets$39,784$44,270$51,553$58,444
Other Assets$0$0$0$0
Total Assets$84,538$71,464$82,946$91,336
Liabilities
Payables$6,912$1,301$1,302$846
Short-Term Debt$529$578$416$317
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,458$11,308$10,871$10,125
Total Curr. Liab.$20,899$13,187$12,589$11,288
LT Debt$1,264$1,565$1,497$1,829
Deferred Rev, NC$0-$1,565$0$0
Deferred Tax Liab, NC$331$4,442$5,073$890
Other NC Liab.$3,296$3,375$0$353
Total NC Liab.$4,891$1,565$1,497$3,072
Other Liabilities$0$0$0$0
Cap. Leases$1,793$2,143$1,913$2,146
Total Liabilities$25,790$14,752$14,086$14,360
Equity
Pref Stock$0$0$0$0
Common Stock$3,787$3,678$3,656$3,281
Retained Earnings-$45,427-$42,151-$116,253-$101,166
AOCI$0$21,886$0$0
Other Equity$100,388$73,299$181,457$174,861
Total Equity$58,748$56,712$68,860$76,976
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$84,538$71,464$82,946$91,336
Net Debt-$15,667-$12,065-$22,152-$26,477